The Carotid Case I Never Did and Why

Slides:

Advertisements

Similar presentations

Evolving Strategies in the Treatment of Peripheral Vascular Disease Ravish Sachar MD, FACC Wake Heart and Vascular.

Advertisements

Hybrid Repair of Kommerell’s Diverticulum

Management of AAA Andrew Stanley, MD History HPI HPI 73 yo woman presenting to vascular clinic for routine follow up for AAA. Last measured (6 months.

Sample Disclosure Slide for Presenters

Ted Feldman MD, FACC, FESC, FSCAI Disclosure Information The following relationships exist: Grant support: Abbott, BSC, Edwards, St Jude, WL Gore Consultant:

Complex Iliac Case Sahil A. Parikh, MD, FACC, FSCAI Assistant Professor of Medicine Director, Center for Research and Innovation Director, Experimental.

Mesenteric Ischemia: A Minimally Invasive Approach

Antegrade Femoral Artery Access

William A. Gray, MD DISCLOSURES Consulting Fees

MY WORST CASE OF THE YEAR

CAROTID STENTING: Step-by-Step Technique

William A. Gray, MD DISCLOSURES Consulting Fees

New Stent Designs Applicable for Renal Intervention

LIVE CASE PRESENTATION MOUNT SINAI CARDIAC CATH LAB

OUS Data: What does the CE Mark Really Mean?

What’s new in carotid intervention?

Carotid Artery Stenosis

Guideliner related stent stripping

Is There a Need to Address AF in patients Undergoing Valve Surgery?

CQC Amit Gossain.

Director: Center for Critical Limb Care Riverside Methodist Hospital

Carotid Artery Stenting Predictors of procedural and clinical success

Aorta Infrarenal Stenosis: BE, SE or Covered Stents? CRT 2012

Zeeshan Khan, MD Second Year Cardiology Fellow

Manageing and Avoiding Complications in CAS

TEVAR for Chronic Type B Dissection

CRT Washington, D.C. February 23, 2010 Tim A. Fischell, M.D. FACC

Procedural factors associated with PCI-related ischemic stroke

Three-Year Results Gore VIBRANT Clinical Study

One-Year Interim Results

TAVI „Catch me if you can!“

Columbia University College of Physicians and Surgeons

EVEREST II 5-Year Report and Beyond

Renal CTA: Can We Determine Who Will Benefit from RAS

L. Nelson Hopkins, MD DISCLOSURES Consulting Fees

CRT 2010 Washington DC, January 21, 2010

Rabih A. Chaer MD Assistant Professor of Surgery

Slow-Flow During Carotid Intervention

Selecting Patients Best Suited for CEA

CRT 2010 Washington DC, January 21, 2010

Medical Director of the Vascular Center

Instent Restenosis and Occlusion: Time for Surgical Revision?

Gary M. Ansel, MD, FACC, SCAI Riverside Methodist Hospital

Case Presentation: SFA or BTK DES

Faculty Disclosure Off-Label Product Use

DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.

Part I Who should disclose at my CME event?

Focal renal artery stenosis Post stent placement

Faculty Disclosure Off-Label Product Use

Retrograde migration of an abdominal aortic aneurysm endograft leading to postoperative renal failure Barry T. Katzen, MD, Alexandra A. MacLean, MD,

An Unusual Case of Post-stent Carotid Artery Stenosis with Successful Operative Repair: A Case Report H. Mistry, A. Currie, C. Lioupis, M. Tyrrell, D.

John Ochsner Heart and Vascular Institute

DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.

DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.

DISCLOSURE INFORMATION

DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.

Disclosures The project was funded from the following sources:

Combined open and endovascular treatment of a saccular aneurysm and redundant loop of the internal carotid artery Magdiel Trinidad-Hernández, MD, Joseph.

Faculty Disclosure Off-Label Product Use

Title of Talk Speaker name.

DISCLOSURE INFORMATION

DISCLOSURE SLIDE i. EITHER please state your disclosures including, but not limited to, - Personal financial interests, incl. honoraria you have received.

Faculty Disclosure Off-Label Product Use

Faculty Disclosure Off-Label Product Use

Mark A. Farber, MD, Robert R. Mendes, MD Journal of Vascular Surgery

A new approach to carotid angioplasty and stenting with transcervical occlusion and protective shunting: why it may be a better carotid artery intervention

Please include this slide if you answered “yes” to at least one of the questions.

Carotid Endarterectomy

Transfemoral CAS and TCAR

Julia Seeger et al. JCIN 2017;j.jcin

Presentation transcript:

The Carotid Case I Never Did and Why Gary M Ansel MD FACC Riverside Methodist Hospital Ohio Health Columbus, Ohio

Gary M. Ansel, MD Honoraria: Consulting Fees: Cardiometrics W.L. Gore and Associates,Inc./Embolitech Consulting Fees: Cardiometrics Covidien/Ev3 Flexible Stenting Solutions Nellix, Inc.

Vascular Think Tank/Becher VSG Vatrix Medical Best Doctors Consulting Fees: Nexeon Ostial Solutions SimSuite Vascular Think Tank/Becher VSG Vatrix Medical Best Doctors Vascular Performance Products

Royalty: Veryan/Novate Ownership Interest (stock, stock options, or other ownership interests): Embolitech

My presentation will include off label discussions: Stents

The Carotid Case I Never Did 78 y.o. female Pt with hx of TIA PMHx HTN Hyperlipidemia Bruits on exam Carotid Duplex from outside institution

Type II Aortic Arch

Rt Carotid Angiogram

CAS Risk Factors WHEN IS CAS High Risk Sx (hot) lesion… Elderly pts… Low GSM… Pre dil without EP … Tortuousity- perilesional Aortic Arch disease… Multiple stents… Filter Duration… Concentric calcium… Renal Failure...

Proximal EP Decreasing Risk? Sx (hot) lesion… Elderly pts + easy anatomy Low GSM… Pre dil without EP … Tortuousity- perilesional Aortic Arch disease… Multiple stents… Duration Filter… Concentric calcium… Renal Failure...